Higher expression of DUSP1 was observed in high-grade serous ovarian cancer (HGSOC), which severely affects progression-free survival (PFS) and overall survival (OS) in patients due to therapy resistance.88 This evidence concerns the gene DUSP1 and ovarian serous adenocarcinoma.